Stories – Innovation

Eileen Bauer and Thomas Krakowiak promote occupational health

Eileen Bauer and Thomas Krakowiak promote occupational health An own prevention and fitness center for the Campus? Regular sports courses and health days on topics such as stress reduction or nutrition? And all of this is supported jointly by the institutions and companies on campus? Since 2016, there has been

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT Magnetic resonance imaging (MRI) is a method for diagnosing diseases and monitoring the course of therapy. It produces sectional images of the human body without using harmful radiation. Typically, the water molecules

DR. ELISA KIEBACK AND DR. JEANETTE LIBERA-KÖRNER DRIVE “T-KNIFE” FORWARD

DR. ELISA KIEBACK AND DR. JEANETTE LIBERA-KÖRNER DRIVE “T-KNIFE” FORWARD T-knife is a spin-off company of the Max Delbrück Center for Molecular Medicine (MDC), founded in 2017 by Professor Thomas Blankenstein, Dr. Elisa Kieback and Holger Specht. Located on Campus Berlin-Buch, T-knife develops T-cell therapeutics that

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies Dr. Andreas Eckert is not directly involved in research to find cures for diseases, but he has dedicated his career to the life sciences. His objective is to invest in promising companies in the early phase of their development, which he does with

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body Dr. Ralf Krähmer never thought he would one day found a company in Berlin-Buch. Following his chemistry studies in Leipzig, Dr. Krähmer went to the U.S. for a research stay. From there he went to Switzerland and then on to Berlin, where he for the

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation The prospect that the first clinical trials will lead to the successful treatment of patients inspires and motivates the team of OMEICOS Therapeutics GmbH. All previous data suggest that the scientists and founders have for the first time found a

News Leben

"Wie dem Klimawandel begegnet werden kann" (Folge 11 des LNDW Podcasts)

Expertinnen und Experten ist schon lange klar: Wir stecken mitten im Klimawandel, den wir als Menschheit selbst verursacht haben. Klar ist auch, dass wir den Klimawandel nicht mehr werden aufhalten kö...

more ...

Aktion zum Equal Pay Day am 10. März 2021

Noch immer ungleiche Bezahlung von Frauen und Männern

more ...

Pankow tritt Bündnis „Kommunen für biologische Vielfalt“ bei

In der Konsequenz soll in Zukunft darauf geachtet werden, dass sämtliche Stadtentwicklungsprojekte und Infrastrukturvorhaben sich mit den Zielen des Artenschutzes vertragen und umsetzbar sind ohne die...

more ...

Events Buch Berlin

27.04.2021, 09:00
Epigenetik und die große Frage: Beeinflusst die Umwelt unser Erbgut?

Die Epigenetik bietet konzeptionell neue Ansätze für das Verständnis genetischer Regulation von Entwicklungs- und Erkrankungs-Prozessen.

more ...

14.09.2021, 09:00
GMP Biotech Summer School

Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)

more ...

17.02.2022, 09:00
Pharmacokinetics - Essentials for Project Managers in Biotech Companies

Basics in understanding pharmacokinetics in clinicial development - for non-physicians

more ...

This website is supported by: